Alnylam Pharmaceuticals
ALNY
#575
Rank
โ‚ฌ33.65 B
Marketcap
260,94ย โ‚ฌ
Share price
-2.11%
Change (1 day)
62.23%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company